.svg){kind=small}
Where to Buy
Cosmec Healing is stocked at 42 licensed dispensaries across Maryland, with the deepest coverage in Baltimore, Silver Spring, Annapolis, Upper Marlboro, and Bethesda. Search by ZIP code or city below to find the closest one.
Market Insights Snapshot
In August 2026, Cosmec Healing concentrated 95.57% of sales in Topical while Tincture & Sublingual held 4.43%, indicating an extreme skew in category mix that widened year over year as Topical grew 154.80% YoY versus 32.00% YoY for Tincture & Sublingual. Month over month, Topical contracted 4.64% while Tincture & Sublingual expanded 39.21%, and the average price fell 19.78% YoY to $38.73 alongside a 2-to-1 category rank in Topical within Maryland, implying that volume expansion rather than price drove the YoY gains. The pattern implies Cosmec Healing is dominating a single category while using lower prices and incremental diversification to offset recent Topical softness.
The mix shift suggests a positioning anchored in therapeutic formats where Topical’s scale (95.57% share and rank 2 in Maryland) provides visibility, while the 39.21% MoM surge in Tincture & Sublingual serves as an adjacent entry that could hedge against Topical’s 4.64% MoM pullback. With brand-level sales up 144.70% YoY but pricing down 19.78%, the brand is effectively trading margin for share, and the divergent MoM trajectories imply near-term resource allocation should favor protecting Topical rank while selectively funding Tincture & Sublingual where conversion momentum is evident.
Competitive Landscape
Cosmec Healing is ranked #2 in MD Topical in August 2026, up 1 rank from #3 year over year, after improving from #3 in May 2026 to a peak of #1 in July 2026. Avexia sits at #1 now but moved down from #2 year over year while its sales fell 16.0%, and Doctor Solomon's slid from #1 to #3 alongside a 47.0% sales decline. With competitors at #1 and #3 both posting double-digit contractions and Cosmec Healing narrowing the gap by 1 rank YoY and climbing 2 positions between June 2026 and July 2026, the trajectory implies durable share capture potential if the brand sustains top-2 positioning into September 2026.
Notable Products
CBG/THCV/CBD Dayshift Tincture (600mg CBG, 300mg THCV, 1200mg CBD) posted the sharpest movement in August 2026 with +692.4% MoM to rank 4, while CBN/CBD 2:1 Relax Tincture (600mg CBN, 1200mg CBD, 30ml) fell -63.7% MoM to rank 6, indicating a pivot toward daytime and functional formulations over sleep-led options. The flagship CBD/CBN/THC 4:2:1 Recovery Salve (1000mg CBD, 500mg CBN, 250mg THC) held rank 1 despite a -6.5% MoM decline, and the CBD/CBN 2:1 Recovery Transdermal rose +221.2% MoM to rank 6, putting Topicals at two of the top seven ranks and concentrating pain-recovery use cases. Within Tincture & Sublingual, four of the top ten are tincture SKUs and two grew over +120% MoM (CBC/CBD 1:2 Relief Tincture at +120.2% and CBG/CBD 2:1 Connect Tincture at +54.7% to rank 3), suggesting mix shift toward multi-cannabinoid daytime relief rather than sedative CBN formats. The product mix implies Cosmec Healing is reallocating demand from legacy salves toward diversified tinctures that target functional use cases, a setup that can expand basket breadth even if the top salve moderates in dollars ($44,888).
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
